The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients

Authors

Paul Hofman
George A Calin
Sandurai A Mani
Christophe Bontoux
Marius Ilié
Ignacio I Wistuba

Publication Date

9-4-2022

Journal

Cancers

Abstract

We are proud and happy to present this Special Issue, a follow-up to the third joint meeting on lung cancer of the FHU OncoAge (University Côte d’Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA), which was held virtually on 4 October 2021. This meeting was devoted to better understanding new mechanisms of lung carcinogenesis and novel therapeutic options for lung cancer patients. Moreover, some promising biomarkers for non-small cell lung carcinoma (NSCLC) were also discussed.

DOI

10.3390/cancers14174327

PMID

36077862

PMCID

PMC9454909

PubMedCentral® Posted Date

9-4-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes